glp-1 pregnancy news today New Moms' Prescriptions Jumped After Wegovy Approval glp-1 pregnancy safety news today

As of July 31, 2025, the FDA has received: Some of these reports involve serious reactions such as nausea, vomiting, abdominal pain, constipation, and dosing errors, especially when patients or providers miscalculate injections or exceed FDA-approved dosing schedules

They work by slowing stomach emptying, reducing appetite, and supporting blood sugar regulation

The genetics of schizophrenia and bipolar disorder: dissecting psychosis

Previous serious hypersensitivity reactions, current pregnancy (especially for weight-loss indications), active pancreatitis and severe gastroparesis generally contraindicate use

We teach our daughters to be resilient

GLP-1 is a naturally occurring hormone in the small intestine